The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Sulodexide (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Acronyms SUN-MICRO
- Sponsors Keryx Biopharmaceuticals
- 07 Mar 2008 Primary endpoint not met: results announced by Keryx.
- 11 Feb 2008 Status changed to completed in accordance with media release 9085123.
- 05 Dec 2007 A review by the Data Safety Monitoring Committee found no reason to recommend alteration or termination of the trial.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History